4.8 Article

PCAT-1, a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer

期刊

CANCER RESEARCH
卷 74, 期 6, 页码 1651-1660

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-13-3159

关键词

-

类别

资金

  1. Prostate Cancer Foundation
  2. NIH Prostate Specialized Program of Research Excellence [P50CA69568]
  3. Department of Defense [PC094231, PC100171]
  4. Early Detection Research Network [UO1 CA111275]
  5. Prostate Cancer Foundation-Movember Challenge Award
  6. U.S. National Institutes of Health [R01CA132874-01A1, R01CA152057]
  7. National Center for Functional Genomics
  8. Department of Defense
  9. Doris Duke Charitable Foundation Clinical Scientist Award
  10. Howard Hughes Medical Institute
  11. Department of Defense Fellowship [PC094290, BC100238, PC094725]

向作者/读者索取更多资源

Impairment of double-stranded DNA break (DSB) repair is essential to many cancers. However, although mutations in DSB repair proteins are common in hereditary cancers, mechanisms of impaired DSB repair in sporadic cancers remain incompletely understood. Here, we describe the first role for a long noncoding RNA (lncRNA) in DSB repair in prostate cancer. We identify PCAT-1, a prostate cancer outlier lncRNA, which regulates cell response to genotoxic stress. PCAT-1 expression produces a functional deficiency in homologous recombination through its repression of the BRCA2 tumor suppressor, which, in turn, imparts a high sensitivity to small-molecule inhibitors of PARP1. These effects reflected a posttranscriptional repression of the BRCA2 3'UTR by PCAT-1. Our observations thus offer a novel mechanism of BRCAness in sporadic cancers. (C) 2014 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据